Related Experiment Video
Updated: Jul 6, 2026
16:38
Bridging the Bio-Electronic Interface with Biofabrication
Published on: June 6, 2012
Interaction behaviors between chitosan and hemoglobin
1School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, Jinagsu, 25002, PR China.
International Journal of Biological Macromolecules
|April 9, 2008
Summary
Chitosan associates with hemoglobin (Hb), forming complexes that alter Hb's structure. This interaction impacts Hb's microstructure and secondary structure, specifically changing alpha-helices to beta-sheets.
Area of Science:
- Biochemistry
- Materials Science
- Protein Chemistry
Background:
- Hemoglobin (Hb) is crucial for oxygen transport.
- Chitosan is a biocompatible polymer with diverse applications.
- Understanding protein-polymer interactions is key for biomaterial development.
Purpose of the Study:
- To investigate the interaction and association between chitosan and hemoglobin.
- To elucidate how chitosan binding affects hemoglobin's microstructure and secondary structure.
Main Methods:
- Utilized UV-vis and fluorescence spectroscopies.
- Employed viscometry, circular dichroism (CD).
- Applied dynamic and static light scattering techniques.
Main Results:
- Chitosan readily associates with Hb, forming distinct protein-chitosan complexes.
- Hb microstructure is significantly altered upon complex formation.
- Observed an increase in Hb's intrinsic UV-vis absorption and fluorescence with rising chitosan concentrations.
- Chitosan binding induced a conformational change in Hb, transforming alpha-helices into beta-sheets.
Conclusions:
- Chitosan and Hb form stable complexes, influencing Hb's structural integrity.
- The study quantifies the interaction site distance and spectral changes.
- Chitosan binding induces significant secondary structure modifications in hemoglobin.
Related Concept Videos
01:19Complexation Equilibria: The Chelate Effect
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
01:24Hemoglobin
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
01:30Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...